Who Paid My Doc
Brian Coan
Plastic and Reconstructive Surgery Cary, NC Medical Doctor
NPI 1255598736 CMS profile 684521
2001 Weston Pkwy, Cary, NC 27513
General payments
$41,166
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$24,214
Through program year 2025, Brian Coan of Cary, NC is reported in the CMS Open Payments database as having received $41,166 across 120 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $24,214 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 94th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $691 | 15 | |
| 2024 | General | $5,985 | 13 | |
| 2023 | General | $10,586 | 18 | |
| 2022 | General | $2,263 | 13 | |
| 2021 | General | $1,959 | 28 | |
| 2020 | General | $1,869 | 9 | |
| 2019 | General | $17,814 | 24 |
Beside peers
- Brian Coan
- Plastic and Reconstructive Surgery median
- Middle half of Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to Brian Coan were reported at $691. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.
Show as a table
| Year | Brian Coan | Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $17,814 | $335 | $121–$1,264 | $163 |
| 2020 | $1,869 | $162 | $57–$417 | $114 |
| 2021 | $1,959 | $245 | $89–$735 | $132 |
| 2022 | $2,263 | $325 | $120–$932 | $149 |
| 2023 | $10,586 | $343 | $129–$999 | $160 |
| 2024 | $5,985 | $390 | $141–$1,085 | $164 |
| 2025 | $691 | $442 | $150–$1,242 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
120 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Plastic and Reconstructive Surgery in North Carolina
Jeffrey Marcus
Plastic and Reconstructive Surgery · Durham, NC
Anuja Antony
Plastic and Reconstructive Surgery · Cary, NC
Peter Arnold
Plastic and Reconstructive Surgery · Greensboro, NC
Joseph Hunstad
Plastic and Reconstructive Surgery · Charlotte, NC
Charles Hultman
Plastic and Reconstructive Surgery · Raleigh, NC
Charles Kays
Plastic and Reconstructive Surgery · Wilmington, NC
Related records
Plastic and Reconstructive Surgery in North Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in North Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.